![]() ![]() | Venit, T.* , Blavier, J.* , Maseko, S. B.* , Shu, S., Espada, L., Breunig, C., Holthoff, H.-P., Desbordes, S. C., Lohse, M., Esposito, G., Twizere, J.-C.* , & Percipalle, P.*. (2024). Nanobody against SARS-CoV-2 non-structural protein Nsp9 inhibits viral replication in human airway epithelia. Molecular Therapy: Nucleic Acids, 102304. doi:10.1016/j.omtn.2024.102304 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Trepte, P.* , Secker, C.* , Olivet, J.* , Blavier, J.* , Kostova, S., Maseko, S. B., Minia, I., Silva Ramos, E., Cassonnet, P., Golusik, S., Zenkner, M., Beetz, S., Liebich, M. J., Scharek, N., Schütz, A., Sperling, M., Lisurek, M., Wang, Y., Spirohn, K., ... Wanker, E. E.*. (April 2024). AI-guided pipeline for protein-protein interaction drug discovery identifies a SARS-CoV-2 inhibitor. Molecular Systems Biology, 20 (4), 428 - 457. doi:10.1038/s44320-024-00019-8 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Maseko, S. B., Brammerloo, Y., Van Molle, I., Sogues, A., Martin, C., Gorgulla, C., Plant, E., Olivet, J., Blavier, J., Ntombela, T., Delvigne, F., Arthanari, H., El Hajj, H., Bazarbachi, A., Van Lint, C., Salehi-Ashtiani, K., Remaut, H., Ballet, S., Volkov, A. N., & Twizere, J.-C. (21 July 2023). Identification of small molecule antivirals against HTLV-1 by targeting the hDLG1-Tax-1 protein-protein interaction. Antiviral Research, 217, 105675. doi:10.1016/j.antiviral.2023.105675 ![]() |
![]() ![]() | Kim, D.-K., Weller, B., Lin, C.-W., Sheykhkarimli, D., Knapp, J. J., Dugied, G., Zanzoni, A., Pons, C., Tofaute, M. J., Maseko, S. B., Spirohn, K., Laval, F., Lambourne, L., Kishore, N., Rayhan, A., Sauer, M., Young, V., Halder, H., la Rosa, N. M.-D., ... Falter-Braun, P. (10 October 2022). A proteome-scale map of the SARS-CoV-2–human contactome. Nature Biotechnology, 41 (1), 140-149. doi:10.1038/s41587-022-01475-z ![]() ![]() |
![]() ![]() | Olivet, J., Maseko, S. B., Volkov, A. N., Salehi-Ashtiani, K., Das, K., Calderwood, M. A., Twizere, J.-C.* , & Gorgulla, C.*. (2022). A systematic approach to identify host targets and rapidly deliver broad-spectrum antivirals. Molecular Therapy. doi:10.1016/j.ymthe.2022.02.015 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Venit, T.* , Blavier, J.* , Maseko, S. B.* , Shu, S., Espada, L., Breunig, C., Holthoff, H.-P., Desbordes, S. C., Lohse, M., Esposito, G., Twizere, J.-C.* , & Percipalle, P.*. (2024). Nanobody against SARS-CoV-2 non-structural protein Nsp9 inhibits viral replication in human airway epithelia. Molecular Therapy: Nucleic Acids, 102304. doi:10.1016/j.omtn.2024.102304 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Trepte, P.* , Secker, C.* , Olivet, J.* , Blavier, J.* , Kostova, S., Maseko, S. B., Minia, I., Silva Ramos, E., Cassonnet, P., Golusik, S., Zenkner, M., Beetz, S., Liebich, M. J., Scharek, N., Schütz, A., Sperling, M., Lisurek, M., Wang, Y., Spirohn, K., ... Wanker, E. E.*. (April 2024). AI-guided pipeline for protein-protein interaction drug discovery identifies a SARS-CoV-2 inhibitor. Molecular Systems Biology, 20 (4), 428 - 457. doi:10.1038/s44320-024-00019-8 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Maseko, S. B., Brammerloo, Y., Van Molle, I., Sogues, A., Martin, C., Gorgulla, C., Plant, E., Olivet, J., Blavier, J., Ntombela, T., Delvigne, F., Arthanari, H., El Hajj, H., Bazarbachi, A., Van Lint, C., Salehi-Ashtiani, K., Remaut, H., Ballet, S., Volkov, A. N., & Twizere, J.-C. (21 July 2023). Identification of small molecule antivirals against HTLV-1 by targeting the hDLG1-Tax-1 protein-protein interaction. Antiviral Research, 217, 105675. doi:10.1016/j.antiviral.2023.105675 ![]() |
![]() ![]() | Kim, D.-K., Weller, B., Lin, C.-W., Sheykhkarimli, D., Knapp, J. J., Dugied, G., Zanzoni, A., Pons, C., Tofaute, M. J., Maseko, S. B., Spirohn, K., Laval, F., Lambourne, L., Kishore, N., Rayhan, A., Sauer, M., Young, V., Halder, H., la Rosa, N. M.-D., ... Falter-Braun, P. (10 October 2022). A proteome-scale map of the SARS-CoV-2–human contactome. Nature Biotechnology, 41 (1), 140-149. doi:10.1038/s41587-022-01475-z ![]() ![]() |
![]() ![]() | Olivet, J., Maseko, S. B., Volkov, A. N., Salehi-Ashtiani, K., Das, K., Calderwood, M. A., Twizere, J.-C.* , & Gorgulla, C.*. (2022). A systematic approach to identify host targets and rapidly deliver broad-spectrum antivirals. Molecular Therapy. doi:10.1016/j.ymthe.2022.02.015 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Vandermeulen, C., O'Grady, T., Wayet, J., Galvan, B., Maseko, S. B., Cherkaoui, M., Desbuleux, A., Coppin, G., Olivet, J., Ben Ameur, L., Kataoka, K., Ogawa, S., Hermine, O., Marcais, A., Thiry, M., Mortreux, F., Calderwood, M. A., Van Weyenbergh, J., Peloponese, J.-M., ... Twizere, J.-C. (2021). The HTLV-1 viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape. PLoS Pathogens, 17 (9), 1009919. doi:10.1371/journal.ppat.1009919 ![]() |